Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (5y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.60% |
| Jun 30, 2025 | -22.59% |
| Mar 31, 2025 | -26.45% |
| Dec 31, 2024 | -13.14% |
| Sep 30, 2024 | -29.15% |
| Jun 30, 2024 | -100.00% |
| Mar 31, 2024 | -14.06% |
| Dec 31, 2023 | -42.00% |
| Sep 30, 2023 | -54.24% |
| Jun 30, 2023 | -57.73% |
| Mar 31, 2023 | -82.40% |
| Dec 31, 2022 | -67.03% |
| Sep 30, 2022 | -72.04% |
| Jun 30, 2022 | -84.19% |
| Mar 31, 2022 | -69.82% |
| Dec 31, 2021 | -129.66% |
| Sep 30, 2021 | 30.12% |
| Jun 30, 2021 | -6.40% |
| Mar 31, 2021 | -11.84% |
| Dec 31, 2020 | 3.58% |